Skip to content

Dimensional Validation of the Hallux Valgus Orthosis

Dimensional Validation of the Hallux Valgus Orthosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05163431
Enrollment
4
Registered
2021-12-20
Start date
2021-07-20
Completion date
2022-09-30
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Brief summary

The goal of this project is to optimize the design of the orthosis by establishing the key volumetric characteristics of the custom iterations in order to subsequently transpose them to a standard model and establish the increment proportions of the different sizes. The final product should reduce the pain by repositioning the phalanges of the first toe with the first metatarsal in its axis.

Interventions

Custom designed orthosis and manufactured by 3D printing.

Sponsors

Natural Sciences and Engineering Research Council, Canada
CollaboratorOTHER
Orthèse Hallux Valgus Inc.
CollaboratorUNKNOWN
TOPMED
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Painful hallux valgus * three people maximum per shoe size

Exclusion criteria

* People with diabetes ; * People with severe obesity ; * People with hallux rigidus; * People wearing full-time foot orthosis; * People wearing high heel shoes regularly ; * People with degenerative disease ; * People with neuromuscular pathology ; * People with a circulatory disorder ; * People who have had major lower body surgery; * People with epilepsy or with a history of epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
Change in big toe deviation angle during gait at 1 monthAt baseline and 1 monthThe big toe deviation angle is the angle between the big toe and the gait axis and measured with a motion capture system.
Change in pain at 1 monthAt baseline and 1 monthPain is measured with a Likert scale from 1 (decrease of pain) to 5 (increase of pain).
Change in comfort at 1 monthAt baseline and 1 monthComfort is measured with a Likert scale from 1 (not comfortable) to 5 (very comfortable).

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026